ALTSTATION.IO

Blackstone Inc. (BX) Stock Analysis

By Nova Skye | AltStation.io | Updated September 19, 2026

Price
$134.44
Change
-1.26%
Market Cap
$160.70B
Avg Volume
4.6M

Company Overview

Blackstone Inc. (BX) is an alternative asset manager based in New York that invests capital across private equity, real estate, hedge fund solutions, credit, and public markets. Founded in 1985, the firm operates in the Asset Management segment of the Financial Services sector, managing capital across North America, Europe, Asia, and Latin America. They sell investment strategies and fund management services to clients seeking exposure to private markets, while also providing capital markets services. The company targets businesses with enterprise values between $500 million and $5,000 million, deploying between $0.25 million and $900 million per transaction.

Blackstone operates as a heavyweight in alternative asset management, using massive cross-asset reach from commercial real estate to private credit as its main competitive edge. Their distinct strength lies in handling everything from seed-stage checks up to $900 million buyouts, alongside fund of funds equity commitments up to $300 million. The primary threat to their model stems from substantial exposure to non-investment grade corporate credit, distressed debt, and commercial real estate dislocations. Operating with a three-year investment period also creates constant deployment pressure against rival asset management firms competing for the same buyout and growth assets.

Blackstone is actively deploying capital across both high-growth modern sectors and physical infrastructure rather than narrowing its focus. The firm continues to push into specialized segments like renewable power generation, enterprise software, life sciences, and physical real estate development through subsidiaries like South City Projects. Rather than retreating from credit risk, their credit division remains aggressively committed to financing non-investment grade firms across senior debt, subordinated debt, and equity structures. Operating across North America, Europe, Asia, and Central America, the firm maintains an expansive multi-asset stance built to capture upside across both distressed corporate situations and stabilized income properties.

Key Financials
Market Cap
$160.70B
Revenue
$15.48B
EBITDA
N/A
Gross Margin
100.0%
Profit Margin
22.7%
Revenue Growth
28.6%
Total Cash
$2.66B
Total Debt
$15.30B
Free Cash Flow
N/A


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
30.08
Forward P/E
17.95
Beta
1.56
52-Week High
$190.09
52-Week Low
$101.73
EPS
$4.47
50-Day Avg
$132.59
200-Day Avg
$130.82
Price/Book
11.93
BX 52-Week Stock Chart
Technical Analysis
BX trades at $134.44, 41% of the way from its technical 52-week low of $99.78 to its high of $182.68. The stock is 26.66% below that high but remains 34.27% above the low. Price sits 5.61% below the 20-day moving average of $141.93, confirming weak near-term momentum. BX has fallen 6.47% over the last five trading days and 5.43% over the last 20. Near-term support is $126.46, while resistance stands at $149.32.


Recent News and Developments

Blackstone reshuffles real estate leadership

Global real estate head Nadeem Meghji will leave Blackstone at year-end. David Levine and Giovanni Cutaia were appointed co-heads of the business. Source: Bloomberg Law

Blackstone weighs $2 billion ZO Skin Health sale

Blackstone is exploring a sale of ZO Skin Health at a valuation of around $2 billion. The firm is working with Citigroup and Raymond James, but the process remains at an early stage. Source: Reuters

Blackstone pursues stake in IIFL Finance

Blackstone is in talks with Fairfax Financial and other shareholders about buying a stake in Indian non-bank lender IIFL Finance. Fairfax is considering selling its entire holding to meet regulatory requirements tied to its proposed IDBI Bank acquisition. Source: Business Standard



Market Sentiment and Analyst Recommendations

Bull Case
Revenue grew 28.6% to $15.48 billion, giving the bull case real fundamental support. Analysts rate BX a buy, with 21 analysts contributing to that recommendation. Their average target is $144.05, above the current price of $134.44, while the high target reaches $184.00. A potential ZO Skin Health sale valued around $2 billion could create a meaningful monetization event if completed. Blackstone is also pursuing a stake in IIFL Finance and may participate in more than $3 billion of Waymo debt priced over 500 basis points above the benchmark. The stock is 26.66% below its technical 52-week high, giving buyers room for upside if growth holds and sentiment improves.
Bear Case
BX trades at 30.08 times earnings, a demanding valuation while the stock is losing momentum. The shares are down 6.47% over five trading days and remain 5.61% below the 20-day moving average. Blackstone carries $15.30 billion in total debt against $2.66 billion in total cash, leaving the balance sheet exposed if financing conditions tighten. Investors requested withdrawals equal to about 10% of the $77.2 billion Blackstone Private Credit Fund, while the fund agreed to repurchase only 5%. That redemption gap is the clearest immediate risk because it could pressure confidence in Blackstone’s private-credit platform. The departure of global real estate head Nadeem Meghji at year-end adds leadership execution risk during an already fragile period for the shares.
What to Watch
Watch whether BX holds the $126.46 near-term support level; a break would confirm that selling pressure is still in control. A recovery above the $141.93 moving average would be the first sign that momentum is improving. The stronger technical test is $149.32 resistance, which BX must clear to establish a more constructive near-term trend. Monitor redemption requests at the $77.2 billion Blackstone Private Credit Fund and whether they continue to exceed the 5% repurchase level. Track progress on the potential $2 billion ZO Skin Health sale, the IIFL Finance stake discussions and the proposed Waymo financing of more than $3 billion. Investors should also watch the real estate leadership transition ahead of Nadeem Meghji’s year-end departure and whether David Levine and Giovanni Cutaia maintain execution.
Analyst Consensus
BUY

Based on 21 analyst opinions
Low Target
$119.00
Mean Target
$144.05
High Target
$184.00


Earnings and Financial Data

Sector
Financial Services
Industry
Asset Management
Employees
5,285
Earnings & Dividends
Next Earnings
Oct 22, 2026
EPS (Trailing)
$4.47
Dividend Yield
384.0%
Payout Ratio
111.2%

Frequently Asked Questions

Is BX a good stock to buy?
BX carries a buy recommendation based on 21 analysts, and revenue growth is 28.6%. Takeaway: analysts are positive, but the current technical trend is weak.
What is the BX analyst price target?
The average analyst target is $144.05, with estimates ranging from $119.00 to $184.00. Takeaway: the consensus target is above the current $134.44 price.
Is BX stock overvalued?
BX trades at a P/E ratio of 30.08 and has a market capitalization of $160.70 billion. Takeaway: investors are paying a substantial earnings multiple for the company’s growth.
What are the support and resistance levels for BX?
Near-term support is $126.46, and near-term resistance is $149.32. Takeaway: those are the key levels to watch around the current $134.44 price.
How strong is BX stock momentum?
BX has fallen 6.47% over five trading days and 5.43% over 20 trading days, while trading 5.61% below its $141.93 moving average. Takeaway: near-term momentum is negative.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated September 19, 2026.